Stephen V Liu

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

Stephen V Liu
Nov 21, 2024, 16:32 | Blog
The IASLC Academy is accepting applications from early career professionals in Thoracic Oncology
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:…
Nov 19, 2024, 13:43 | Insight
Highlights from New York Lung Cancers Symposium 2024 by Stephen V Liu
The New York Lung Cancers Symposium 24 (NYLung24) took place on 16th of November 2024,…
Nov 14, 2024, 00:05 | Blog
Stephen V Liu: Federico Cappuzzo on perioperative immunotherapy at VIII Thoracic Oncology Conference
Stephen V Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown…
Nov 13, 2024, 16:08 | Blog
Evolving role of Radiation in early stage NSCLC by Dr. Annalisa Nardone
Stephen V Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown…
Nov 10, 2024, 02:12 | Blog
Applications open for the 2025 IASLC Academy
Stephen V Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics and Associate Professor…
Oct 29, 2024, 10:11 | Insight
Stephen V Liu: Real-world 5-year survival with first line pembrolizumab in PD-L1 high NSCLC
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:…
Oct 28, 2024, 14:45 | Blog
Stephen V Liu: Immunotherapy for NSCLC discussed at the Emirates Oncology Society meeting
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:…
Oct 23, 2024, 17:34 | Insight
Episode of Lung Cancer Considered on the new management of relapsed SCLC
IASLC shared on X: “In this episode of Lung Cancer Considered, host Stephen V Liu…
Oct 22, 2024, 15:58 | Blog
Registration for the 3rd annual TexasLung25 is LIVE - TLC Conference
TLC Conference (Texas Lung Cancer Conference) shared a post on X: ''Registration for the 3rd…
Oct 22, 2024, 08:02 | Insight
Stephen V Liu: Jennifer A. Marks updates on KRAS, sotorasib and adagrasib
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:…
Oct 22, 2024, 00:30 | Blog
Stephen V Liu: Looking forward to speaking at the lung cancer session of the 42nd CFS meeting
Stephen V Liu posted on X: "Register for the 42nd CFS meeting in New York…
Oct 21, 2024, 12:59 | Insight
Highlights from The D.C. Lung Cancer Conference 2024
The D.C. Lung Cancer Conference 2024, took place on October 19th in Washington, D.C. It…
Oct 20, 2024, 19:52 | Blog
Stephen V Liu: Case report in Annals of Oncology of patients with NUT carcinoma responding to lurbinectedin
Stephen V Liu shared a post on X, about recent case report published in Annals…
Oct 20, 2024, 17:47 | Drugs
Stephen V Liu: Long-term survival with nivolumab and ipilimumab in advanced NSCLC
Stephen V Liu shared on X: "Long-term survival (median f/u 73.7m) with nivolumab and ipilimumab…
Oct 20, 2024, 17:43 | Blog
Stephen V Liu: Huge potential utility of LB for early stage lung cancer explained by Christian Rolfo
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared on X: “Huge potential…
Oct 20, 2024, 14:51 | Blog
Stephen V Liu: Ryan Gentzler breaks down adjuvant immunotherapy for NSCLC at DCLung24
Stephen V Liu, Associate Professor of Medicine at Georgetown University, posted on X: "Dr. Ryan…
Oct 20, 2024, 13:22 | Blog
Christian Rolfo: Starting the DC Lung 2024 with the welcome by Stephen V Liu
Christian Rolfo, Division Director of Medical Oncology and Associate Director for Early Phase Clinical Trials…
Oct 18, 2024, 16:52 | Blog
Oncology Brothers: Lung Cancer Highlights from ESMO24 with Stephen V Liu
Oncology Brothers posted on X: "Lung Cancer Highlights ESMO24 with Stephen V Liu Updates on:…
Oct 17, 2024, 20:55 | Blog
Stephen V Liu: Join us at the Grand Hyatt in Washington, DC for the DC Lung Cancer Conference
Stephen V Liu posted the following on X: “Join us at the Grand Hyatt in…
Oct 16, 2024, 18:00 | Insight
Stephen V Liu: Is immunotherapy effective for HER2 mutant NSCLC?
Stephen V Liu shared on X a recent paper by Yuki Kato et al. titled…
Oct 15, 2024, 16:30 | Blog
Important ad hoc analysis of JCOG 0802 for local recurrence
Elliot Servais, Associate Professor of Surgery, UMass Chan Medical School, Tufts University School of Medicine,…
Oct 14, 2024, 13:40 | Insight
Retrospective report on EGFR mutant NSCLC transformed to SCLC, suggested by Stephen V Liu
Stephen V Liu shared a post on X: "Retrospective report in European Journal of Cancer on…
Oct 12, 2024, 17:30 | Blog
Stephen V Liu: Should patients with stage III ALK NSCLC receive adjuvant alectinib alectinib?
Stephen V Liu shared a post on X: "POLL: For patients with resected stage III…
Oct 9, 2024, 16:38 | Blog
Stephen V Liu: Case report of MET mediating resistance to entrectinib in ROS1 NSCLC
Stephen V Liu shared a post on X: "Case report of MET mediating resistance to entrectinib…
Oct 9, 2024, 09:45 | Blog
Stephen V Liu: Amin Benyounes will speak at DC Lung24 on NTRK and NRG1 fusions
Stephen V Liu shared on X: "Dr. Amin Benyounes will speak at DC Lung24 on…
Oct 8, 2024, 01:45 | Blog
Stephen V Liu: Jordi Remon discusses perioperative IO for NSCLC at ILCS24
Stephen V Liu shared a post on X: "Dr. Jordi Remon discusses perioperative IO for NSCLC…
Oct 7, 2024, 15:38 | Insight
Stephen V Liu: Afatinib and Bevacizumab in EGFR NSCLC
Stephen V Liu posted the following on X: “Phase II ABCD study of afatinib and…
Oct 7, 2024, 09:13 | Blog
Yuji Uehara: Meet the Expert session on Nov 1 at the Japan Lung Cancer Society
Yuji Uehara, Medical Oncologist, National Cancer Center, Japan, shared a post on X: "Stephen V…
Oct 6, 2024, 12:22 | Insight
Stephen V Liu: Randomized phase II trial results on amrubicin vs cisplatin for SCLC
Stephen V Liu posted the following on X: “Randomized phase II: 1L amrubicin + irinotecan…
Oct 5, 2024, 13:04 | Insight
Highlights from ILCS24 by Stephen V Liu
The 6th International Lung Cancer Summit took place as a hybrid event in Lausanne, Switzerland,…
Oct 5, 2024, 09:30 | Blog
Medicaid expansion increased use of adjuvant therapy for NSCLC
Stephen V Liu shared an article by Hamza Rshaidata on X: "In addition to developing…
Oct 4, 2024, 06:03 | Drugs
FDA approved Neoadjuvant/Adjuvant Nivolumab for resectable NSCLC
FDA Approval Introduces New Treatment Options for Adults with Resectable Lung Cancer Lacking Key Genetic…
Oct 1, 2024, 15:27 | Blog
Stephen V Liu: Eager to join the 6th International Lung Cancer Summit
Stephen V Liu posted on X: "Eager to get back to Switzerland to join the…
Oct 1, 2024, 12:28 | Societies
ASTRO 24: 15 Posts Not to Miss From Day 2
The 66th Annual Meeting of the American Society for Radiation Oncology (ASTRO) is ongoing at…
Sep 30, 2024, 15:52 | Societies
ASTRO24: 20 Posts Not To Miss From Day 1
The 66th Annual Meeting of the American Society for Radiation Oncology (ASTRO) is ongoing at…
Sep 29, 2024, 06:34 | Insight
Picks from Lung Cancer Cocktail With Science by Stephen V Liu
The Lung Cancer Cocktail With Science 2024 conference took place on September 27th in Milan,…
Sep 28, 2024, 07:13 | Blog
Stephen V Liu: Very different healthcare systems - very similar challenges and unanswered questions
Stephen V Liu shared a post on X: "Thanks to colleagues in China for a great…
Sep 27, 2024, 12:43 | Blog
Stephen V Liu: Great talks on immunotherapy and cell therapy at the 2023 Thomas Shea Clinical Cancer Symposium
Stephen V Liu shared a post on X: "Some great talks on immunotherapy and cell…
Sep 26, 2024, 15:37 | Blog
Stephen V Liu: Retrospective report on treatment post osimertinib for EGFR NSCLC
Stephen V Liu shared a post on X, about recent paper published in Clinical Lung…
Sep 26, 2024, 15:26 | Blog
Stephen V Liu: Learned a lot at the head and neck session of the Thomas Shea Symposium
Stephen V Liu shared a post on X: ''Learned a lot at the head and…
Sep 26, 2024, 14:05 | Blog
Stephen V Liu: Real-world study of first-line nivolumab and ipilimumab for pleural mesothelioma
Stephen V Liu shared a post on X, about recent paper published in Clinical Lung…
Sep 25, 2024, 14:41 | Blog
Stephen V Liu: Opening session of the 2024 Thomas Shea Clinical Cancer Symposium
Stephen V Liu posted on X: "Opening session of the 2024 Thomas Shea Clinical Cancer…
Sep 25, 2024, 14:39 | Blog
Stephen V Liu: Stephen R Broderick guides a discussion on early stage NSCLC at DCLung24
Stephen V Liu posted on X: "Stephen R Broderick guides a discussion on early stage…
Sep 24, 2024, 11:04 | Blog
Stephen V Liu: The recent FDA approval of the MARIPOSA-2 regimen for EGFR NSCLC
Stephen V Liu shared a post on X: ''In this episode of the IASLC podcast…
Sep 20, 2024, 13:27 | Blog
Stephen V Liu: FDA approved MARIPOSA2
Stephen V Liu shared on X: “FDA approved MARIPOSA2: amivantamab plus chemotherapy for EGFR NSCLC…
Sep 18, 2024, 13:28 | Blog
Stephen V Liu: An impactful ESMO24
Stephen V Liu shared on X: "An impactful ESMO24 - attending keeps you current with…
Sep 18, 2024, 09:18 | Insight
34 Posts Not to Miss From ESMO24 Day 4
The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at…
Sep 17, 2024, 15:07 | Blog
Stephen V Liu: Data from ARROS-1 study of NVL-520 in ROS1 NSCLC
Stephen V Liu shared a post on X: ''Benjamin Besse presents data from ARROS-1 study…
Sep 15, 2024, 01:34 | Insight
Some perspective on TRUST-II with talectrectinib
IASLC shared on X: “ In this episode, Narjust Florez and Stephen V Liu, recap…
Sep 14, 2024, 06:41 | Societies
Best of WCLC24
The WCLC24 took place at the San Diego Convention Center from September 7 to 10,…
Sep 12, 2024, 16:26 | Societies
35 posts not to miss from WCLC24 Day 4
The WCLC24 is took place at the San Diego Convention Center from September 7 to…
Sep 11, 2024, 16:56 | Blog
Coral Olazagasti: Honored to host the official IASLC Lung Cancer Considered podcast
Coral Olazagasti shared a post on X: "What an honor to host the official IASLC…
Sep 10, 2024, 16:09 | Societies
Highlights from WCLC24 by Stephen V Liu Part 2
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 10, 2024, 11:17 | Insight
Jennifer Marks: Our MET-working paper in collaboration with Caris Life Sciences
Jennifer Marks shared a post on X: “Our MET-working paper in collaboration with Caris Life…
Sep 10, 2024, 11:08 | Societies
Special WCLC24 Lung Cancer Considered episode
IASLC (International Association for the Study of Lung Cancer) shared a post on X: “…
Sep 10, 2024, 05:38 | Blog
WCLC24 Social Media Ambassadors
Narjust Florez shared a post on X: "Our social media ambassadors for WCLC24. Make sure…
Sep 9, 2024, 13:41 | Societies
Highlights from WCLC24 by Stephen V Liu
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 9, 2024, 09:35 | Blog
Maria Antonia Vélez: Excellent talk by Stephen V. Liu on how to give a Master Class on Scientific presentations
Maria Antonia Vélez shared a post on X: ''Excellent talk by Stephen V. Liu on…
Sep 9, 2024, 07:17 | Societies
Julie Brahmer received Paul A. Bunn Scientific Award
WCLC is a major international event focused on the latest advancements in lung cancer research,…
Sep 8, 2024, 13:51 | Societies
20 Posts Not To Miss from Day 1 of WCLC24
The International Association for the Study of Lung Cancer (IASLC) is a global, multidisciplinary organization…
Sep 8, 2024, 12:17 | Blog
Stephen V Liu: "Do You Know Your Targets" Quiz show on September 9th at WCLC24
Stephen V Liu shared a post on X: "Join us at WCLC24 on Monday, September…
Sep 5, 2024, 15:21 | Blog
Stephen V Liu: Mark your calendar for Chemotherapy Foundation Symposium 2024
Stephen V Liu shared a post on X: "With so many updates across cancer types, mark…
Sep 4, 2024, 15:28 | Blog
Hidehito Horinouchi: Early Career Investigator Workshop at WCLC24
Hidehito Horinouchi shared a post on X: ''WCLC24. Early Career Investigator Workshop. Faculties: Narjust Florez, Fabio…
Sep 1, 2024, 18:05 | Insight
Stephen Liu: The role of adjuvant chemotherapy when adjuvant ALK TKI is planned
Stephen Liu shared a post on X: "Dr. Joshua Reuss takes center stage at DC…
Aug 23, 2024, 17:15 | Blog
Brian Shields: AI evaluates recent FDA decision
Brian Shields, Creator of KOL Pulse AI, shared on LinkedIn: "AI evaluates recent FDA decision:…
Aug 23, 2024, 14:21 | Drugs
Stephen V Liu: How do we select the optimal regimen for EGFR NSCLC?
Stephen V Liu shared on X: "With FLAURA (osimertinib alone), FLAURA2 (osimertinib with chemotherapy), and…
Aug 20, 2024, 09:02 | Blog
Stephen V Liu: Join an inspiring WCLC 24 program and celebrate the IASLC 50y
Stephen V Liu shared a post on X: "Join us in 3 weeks for an inspiring…
Aug 19, 2024, 08:29 | Insight
4 leading Chinese lung cancer experts to discuss current research/clinical issues, in Mandarin - IASLC
Stephen V. Liu shared a post by IASLC on X, adding: “Thanks to Drs. Chunxia…
Aug 17, 2024, 15:47 | Blog
Stephen V Liu: Nagla Abdel Karim joins DC Lung24 to discuss targeted therapy in NSCLC
Stephen V Liu shared on X: "Dr. Nagla Abdel Karim joins DC Lung24 to guide discussions…
Aug 16, 2024, 14:13 | Insight
OS rates for IMpower133 and IMbrella A extension study in SCLC
Biagio Ricciuti shared a paper by Martin Reck et al. on X, adding: “Five-year survival…
Aug 14, 2024, 07:04 | Insight
ES-SCLC 5-year survival outcomes inIMpower133 and IMbrella study
Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X, about recent paper…
Aug 13, 2024, 09:57 | Blog
Zosia Piotrowska about what's next for EGFR at DCLung24
Stephen V Liu posted on X: "Dr. Zosia Piotrowska from MGH Thoracic Oncology will discuss…
Aug 12, 2024, 16:45 | Blog
Chul Kim on the advances in treating lung cancer with exon 20 or mutation at DCLung24
Stephen V Liu shared on X: "Dr. Chul Kim will discuss advances in treating lung…
Aug 9, 2024, 06:23 | Blog
Stephen V Liu: The current and future utility of liquid biopsy and ctDNA at DC Lung24
Stephen V Liu posted on X: "Dr. Natasha Leighl will speak at DC Lung24 on…
Aug 8, 2024, 07:50 | Insight
Narjust Florez: Amazing discussion with the leaders that made ALK + NSCLC a treatable disease
Narjust Florez shared a post by IASLC on X, adding: “Amazing discussion with the leaders…
Aug 8, 2024, 02:34 | Blog
Dr. Isabel Preeshagul will discuss perioperative targeted therapy for lung cancer at DCLung24
Stephen V Liu shared on X: “Dr. Isabel Preeshagul will discuss perioperative targeted therapy for…
Aug 7, 2024, 18:01 | Blog
Jarushka Naidoo: Survivorship in Lung Cancer, a great theme to usher in a new era in thoracic oncology
Jarushka Naidoo shared a post by LUNGevity Foundation on X, adding: "Survivorship in Lung Cancer,…
Aug 5, 2024, 14:45 | Blog
Stephen V Liu: Join me at the 19th annual New York Lung Cancers Symposium
Stephen V Liu shared on X: "Join me at the 19th annual New York Lung…
Aug 4, 2024, 06:50 | Insight
Sandip Patel joins DCLung24 with important perspective on artificial intelligence in healthcare
Stephen V Liu shared on X: "Dr. Sandip Patel joins DCLung24 with important perspective on…
Jul 30, 2024, 02:53 | Blog
Giannis Mountzios: Huge pleasure to discuss advances in Precision oncology in NSCLC with Elsa Anagnostou and Ferdinandos Skoulidis
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
Jul 26, 2024, 06:20 | Blog
Hossein Borghaei discusses how CTLA4 remains relevant for NSCLC at DC Lung24
Stephen V Liu shared on X: "Dr. Hossein Borghaei from Fox Chase Cancer Center discusses how…
Jul 26, 2024, 00:27 | Blog
Stephen V Liu: Rapid communication on management of stage III NSCLC by ASCO
Stephen V Liu shared on X: "Latest ASCO rapid communication on management of stage III NSCLC.…
Jul 25, 2024, 21:48 | Insight
Stephen V Liu: What is the role for SRS to brain metastases up front for EGFR or ALK NSCLC?
Stephen V Liu shared a paper by Luke R.G. Pike et al. on X, adding: “What…
Jul 25, 2024, 14:28 | Blog
Stephen V Liu: Alexander Drilon joins DCLung24 to discuss RET fusions in NSCLC
Stephen V Liu shared on X: "Dr. Alexander Drilon joins DCLung24 to discuss RET fusions as…
Jul 24, 2024, 00:57 | Insight
Report on TROP2 expression across tumors
Stephen V Liu shared a paper by Dan Morgenstern-Kaplan et al, on X: "Report on…
Jul 23, 2024, 11:45 | Blog
Stephen V Liu: The International Lung Cancer Survivorship Conference is on September 20-21,2024
Stephen V Liu shared on X: "Join me at ILCSC24 on Sept 20 - 21 with…
Jul 21, 2024, 15:37 | Insight
Neoadjuvant osimertinib for resectable EGFR NSCLC
Stephen V Liu shared on X a recent paper by Collin M. Blakely et al.…
Jul 21, 2024, 09:29 | Blog
Stephen V Liu: Terri Conneran about the patient perspective on the value of research at DC Lung 24
Stephen V Liu shared on X:  . "Excited to welcome Terri Conneran of KRAS Kickers to…
Jul 20, 2024, 17:09 | Opinion
Stephen V Liu: Tina Cascone on Neoadjuvant and Perioperative Immunotherapy For Early Stage NSCLE At DCLung24
Stephen V Liu shared a post on X: "Dr. Tina Cascone from MD Anderson News…
Jul 20, 2024, 01:22 | Blog
Brigatinib in ROS1 NSCLC
Stephen V Liu shared a post on X: ''Brigatinib in ROS1 NSCLC (Phase II Barossa…
Jul 18, 2024, 11:08 | Blog
Stephen V Liu: Retrospective study looks at immunotherapy in patients with NSCLC and autoimmune condition
Stephen V Liu shared on X: "Retrospective NEJ047 study looks at immunotherapy in patients with NSCLC…
Jul 13, 2024, 14:20 | Blog
Samuel Kareff: Pan-tumoral analysis of TROP2 among solid tumors
Samuel Kareff, Hematology/Oncology Chief Fellow at the University of Miami Sylvester Comprehensive Cancer Center, shared…
Jul 10, 2024, 11:53 | Blog
Stephen V. Liu: Pittsburgh Annual Oncology Symposium Experts and Evidence 2024
Stephen V. Liu shared on X: “Join me for an update on Targeted Therapy in…
Jul 8, 2024, 18:02 | Blog
Stephen V. Liu: Brief update at utilization of lung cancer screening in the US
Stephen V. Liu shared on X: “Brief update at utilization of lung cancer screening in…
Jul 7, 2024, 17:51 | Blog
Stephen V. Liu: How do we encourage colleagues and patients to wait for biomarker results?
Stephen V. Liu shared on X: “Faced with an urgency to start therapy for newly…
Jul 7, 2024, 07:04 | Blog
Stephen V. Liu: Can we use ctDNA to personalize use of consolidation immunotherapy after chemoradiation?
Stephen V. Liu shared on X: “Can we use ctDNA to personalize use of consolidation…
Jul 6, 2024, 12:06 | Blog
Real world data on QTc prolongation with osimertinib
Stephen V Liu shared on X: "Real world data on QTc prolongation with osimertinib. 970 pts…
Jul 5, 2024, 10:25 | Blog
Stephen V Liu: Important dates for thoracic oncologists
Stephen V Liu shared on X: "For all thoracic oncologists out there, keep these dates…
Jul 5, 2024, 06:54 | Blog
Estela Rodriguez: Underreported toxicity of myopathy from EGFR TKIs
Estela Rodriguez shared a post by Stephen V Liu, on X: "Important to study under reported toxicity…
Jul 4, 2024, 11:48 | Insight
The Importance of Waiting for Biomarker Results in NSCLC
IASLC (International Association for the Study of Lung Cancer) shared a post on X: "Biomarkers…
12
All: 152 Posts: 1 - 100
Special Coverage